Cargando…
Quantified Striatal Dopaminergic Denervation as Predictor for Motor Outcomes in Parkinson's Disease
BACKGROUND: A hallmark of Parkinson's disease (PD) is progressive loss of dopamine terminals in the basal ganglia, with clinical symptoms including motor and non‐motor manifestations such as bradykinesia, rigidity, and cognitive impairment. Dopamine transporter single‐photon emission computed t...
Autores principales: | Trinh, Ilene, Muralidhar, Angeni, Yang, Justin, Phielipp, Nicolás |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272916/ https://www.ncbi.nlm.nih.gov/pubmed/37332639 http://dx.doi.org/10.1002/mdc3.13726 |
Ejemplares similares
-
Striatal Dopaminergic Loss and Dysphagia in Parkinson Disease
por: Kim, Ji Hwan, et al.
Publicado: (2023) -
Dopaminergic medication reduces striatal sensitivity to negative outcomes in Parkinson’s disease
por: McCoy, Brónagh, et al.
Publicado: (2019) -
Striatal But Not Extrastriatal Dopamine Receptors Are Critical to Dopaminergic Motor Stimulation
por: Wang, Yuhan, et al.
Publicado: (2017) -
Correlation of Dopaminergic Denervation and the Progression of Autonomic Dysfunctions in Different Clinical Subtypes of Parkinson's Disease
por: Jeong, Eun Hye, et al.
Publicado: (2021) -
Molecular Imaging of Striatal Dopaminergic Neuronal Loss and the Neurovascular Unit in Parkinson Disease
por: Ivanidze, Jana, et al.
Publicado: (2020)